Nika Pharmaceuticals, Inc. (NIKA)
OTCMKTS · Delayed Price · Currency is USD
0.4020
0.00 (0.00%)
At close: Apr 24, 2026
Nika Pharmaceuticals Company Description
Nika Pharmaceuticals, Inc. engages in the development and distribution pharmaceutical products for dietary supplements and antiviral drugs in the United States.
The company offers ITV-1, TNG, physiolong, carotilen, fructin, dry boza, anthocylen C, hypocholestin, biodetoxin, silymaron, and solamentum products.
The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022.
Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.
Nika Pharmaceuticals, Inc.
| Country | United States |
| Founded | 2000 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Dimitar Savov |
Contact Details
Address: 2269 Merrimack Valley Avenue Henderson, Nevada 89044 United States | |
| Phone | 702 326 3615 |
| Website | nikapharmaceuticals.com |
Stock Details
| Ticker Symbol | NIKA |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US1513411041 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dimitar Slavchev Savov | President, Chief Executive Officer, Chief Financial Officer and Director |
| Clifford Redekop | Secretary and Director |